Last updated: 2026-09-06 21:42:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
CorMedix Inc. (CRMD) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $8,43, with a market capitalization of $671,10M and a P/E ratio of 3,53. Over the past 52 weeks, its price has ranged from $6,13 to $13,93. This page covers its latest market performance, valuation, price trends and company information.
$671,10M | |
$8,45 | |
$52,00 | |
$0,73 | |
$8,47 | |
688,96K | |
-- | |
3,53 | |
$13,93 | |
$6,13 | |
-- | |
-- |
CorMedix Inc. (CRMD) last closed at $8,47 as of 2026-09-04 23:57:00, unchanged from the previous close of $8,47.
During the latest regular trading session, CRMD traded between $0,73 and $52,00, with a volume of 688,96K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, CorMedix Inc. (CRMD) moved from $8,26 to $8,43, representing a gain of 2,00% ($0,17).
The stock traded between $8,32 and $8,61 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 850,21 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 29,5%
CRMD is currently trading at $8,43, placing it 29,5% of the way from its 52-week low of $6,13 to its 52-week high of $13,93. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 191 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of CorMedix Inc. (CRMD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.